TNL Mediagene Ordinary Shares (TNMG)
Official siteCOMMUNICATION SERVICES • PUBLISHING • NASDAQ
Market Cap: $2.05M
Last updated: Nov 17, 2026 at 11:02 AM ET
TNL Mediagene Ordinary Shares (TNMG) Financials: Revenue, Profit and Cash Flow
TNL Mediagene Ordinary Shares reported revenue of $45.02M for the fiscal year ended Dec 31, 2025, down 7.2% from the year before. That year, net income was -$44.55M with a net margin of -99.0%, operating cash flow was -$4.90M and free cash flow was -$5.30M. The quarter ended Mar 31, 2026 had revenue of $23.24M and net income of -$40.23M.
Revenue and Margins
The operating margin was -22.1% in the fiscal year ended Dec 2025, the lowest of the 3 years shown with an operating margin.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $45.02M | -7.2% | 31.1% | -22.1% | -99.0% |
| Dec 2024 | $48.49M | +35.3% | 36.6% | -157.4% | -175.3% |
| Dec 2023 | $35.84M | +79.1% | 35.3% | -20.6% | -2.2% |
| Dec 2022 | $20.01M | N/A | 38.7% | -17.1% | -55.0% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Mar 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | $45.02M | $48.49M | $35.84M | $20.01M |
| Cost of revenue | $31.04M | $30.76M | $23.19M | $12.27M |
| Gross profit | $13.98M | $17.74M | $12.65M | $7.74M |
| Research and development | $3.12M | $3.05M | $3.33M | $2.51M |
| Operating income | -$9.96M | -$76.34M | -$7.40M | -$3.42M |
| Net income | -$44.55M | -$85.00M | -$804.98K | -$11.01M |
| EBITDA | N/A | -$73.92M | $1.33M | N/A |
Quarterly
| Line item | Mar 2026 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.24M | $21.79M | $10.89M | -$10.30M | $20.61M | $10.30M | $26.89M | $13.41M | $9.01M | $4.51M |
| Gross profit | $6.99M | $6.99M | $3.49M | -$4.09M | $8.19M | $4.09M | $8.76M | $4.35M | $3.95M | $1.98M |
| Operating income | -$4.73M | -$5.64M | -$2.82M | -$26.24M | -$5.57M | -$2.79M | -$2.42M | -$1.39M | -$4.61M | -$2.31M |
| Net income | -$40.23M | -$4.32M | -$2.16M | -$39.54M | -$5.92M | -$2.97M | -$2.22M | -$1.11M | $1.41M | $705.01K |
Balance Sheet
As of Dec 2025, total debt of $18.34M exceeded cash and equivalents by $16.41M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total assets | $49.95M | $92.92M | $119.62M | $26.53M |
| Current assets | $17.59M | $17.72M | $16.85M | $11.07M |
| Cash and equivalents | $1.93M | $3.65M | $3.03M | $3.73M |
| Total liabilities | $49.03M | $56.51M | $47.25M | $50.67M |
| Short-term debt | $14.79M | $12.75M | $9.46M | $3.50M |
| Long-term debt | $3.55M | $6.27M | $3.12M | $2.88M |
| Shareholder equity | $919.25K | $36.40M | $72.62M | -$25.30M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $49.95M | $49.95M | $86.05M | $86.05M | $92.92M | $92.92M | $111.03M | $111.03M | $119.62M | $119.62M | N/A | N/A |
| Total liabilities | $49.03M | $49.03M | $51.19M | $51.19M | $56.51M | $56.51M | $44.60M | -$72.37M | $47.25M | $47.25M | N/A | $24.14M |
| Cash and equivalents | $1.93M | $1.93M | $1.61M | $1.61M | $3.65M | $3.65M | $3.14M | $3.03M | $3.03M | $3.03M | N/A | N/A |
| Shareholder equity | $919.25K | $919.25K | $34.86M | $34.86M | $36.40M | $36.40M | $66.68M | $72.37M | $72.62M | $72.62M | N/A | -$24.14M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | -$4.90M | -$10.21M | -$1.42M | -$760.11K |
| Capital expenditures | $403.52K | $89.12K | $258.72K | $281.65K |
| Free cash flow | -$5.30M | -$10.30M | -$1.68M | -$1.04M |
| Investing cash flow | -$897.27K | $947.95K | $252.74K | -$2.36M |
| Financing cash flow | $3.93M | $10.00M | $530.97K | $4.99M |
Quarterly
| Line item | Mar 2026 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.06M | -$1.84M | -$918.68K | -$4.65M | -$916.07K | -$458.03K | -$837.04K | -$418.52K | -$587.45K | -$293.72K |
| Capital expenditures | $93.15K | $40.05K | $20.03K | $18.29K | $52.53K | $26.27K | $57.02K | $28.51K | $30.15K | $15.08K |
| Free cash flow | -$3.15M | -$1.88M | -$938.71K | -$4.67M | -$968.60K | -$484.30K | -$894.06K | -$447.03K | -$617.60K | -$308.80K |
Frequently Asked Questions About TNMG
What is TNL Mediagene Ordinary Shares' annual revenue?
TNL Mediagene Ordinary Shares reported revenue of $45.02M for the fiscal year ended Dec 31, 2025.
How fast is TNL Mediagene Ordinary Shares' revenue growing?
Revenue was down 7.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 31.0%.
Is TNL Mediagene Ordinary Shares profitable?
No. TNL Mediagene Ordinary Shares reported net income of -$44.55M for the fiscal year ended Dec 31, 2025, with a net margin of -99.0%.
How much free cash flow does TNMG generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$4.90M minus capital expenditures of $403.52K produced free cash flow of -$5.30M.
How much debt does TNL Mediagene Ordinary Shares have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.55M, short-term debt of $14.79M and cash and equivalents of $1.93M.
TNMG pages: Overview, Financials